Activating KIR: iN Kase of KIR-ligand mismatch

Abstract

In this issue of Blood, Mancusi et al demonstrate that haploidentical hematopoietic stem cell transplantation (HSCT) from killer immunoglobulin-like receptor (KIR) ligand-mismatched donors with concomitant activating KIRs reduces nonrelapse mortality (NRM).